CompletedNCT03053362
Tracking Cognitive Changes With THINC-it During Vortioxetine Treatment
About this title
Read the official source — NCT03053362Medication studyAges 18–65CanadaDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: May 24, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 158
- Sponsor
- Brain and Cognition Discovery Foundation
- Sponsor type
- Non-profit organization
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03053362
- Official title
Show the full official title
An Open-Label Clinical Trial Evaluating Sensitivity to Change in Cognition Using the THINC-it Following Treatment With Vortioxetine in Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brain and Cognition Discovery Foundation.
Did this study involve medication?
Yes. The study involved medication, including Vortioxetine.
Who was this study for?
Listed age limits: 18 years to 65 years.
